亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension

医学 工作队 重症监护医学 临床实习 右心导管插入术 临床试验 肺动脉高压 叙述性评论 任务(项目管理) 随机对照试验 确定性 梅德林 疾病 临床研究 循证医学 风险评估 最佳实践 疾病管理 死因 临床判断 心脏病学 系统回顾 呼吸系统
作者
Gábor Kovács,Katarina Zeder,Marc Humbert,Robin Condliffe,Ingrid Toews,Athénaïs Boucly,Micheala Aldred,Roberto Badagliacca,Wendy Chung,Frances De Man,Peter Dorfmüller,Pisana Ferrari,George Giannakoulas,Sergio Harari,T. Kotsimbos,Nicole Ngai Yung Tsang,Rozenn Quarck,Antenor Rodrigues,Stephan Rosenkranz,Olivier Sitbon
出处
期刊:The European respiratory journal [European Respiratory Society]
卷期号:: 2601178-2601178
标识
DOI:10.1183/13993003.01178-2026
摘要

Background Pulmonary arterial hypertension (PAH) is a severe, progressive disease of the small pulmonary arteries. These guidelines provide updated evidence-based recommendations for the treatment of PAH focusing on the latest scientific evidence on sotatercept, an activin signalling inhibitor targeting a novel pathway for the treatment of PAH, and on the role of right heart catheterisation (RHC) in the management of PAH patients during follow-up. Methods A European Respiratory Society (ERS) Task Force, comprising global experts, methodologists and a patient representative, developed these clinical practice guidelines in accordance with ERS methodology and the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) approach. Four PICO (Patients, Intervention, Comparator, Outcomes) questions and one narrative question have been addressed. Recommendations The Task Force recommends add-on treatment with sotatercept in PAH patients who already receive PAH drugs and are at intermediate-low, intermediate-high or high risk of death during follow-up; this recommendation is based on a high certainty of evidence available from randomised controlled trials (RCTs). In PAH patients at low risk of death, the Task Force does not provide a recommendation due to the low certainty of evidence and the limited number of such patients included in RCTs. To monitor safety and efficacy, patients receiving sotatercept should be treated in pulmonary hypertension centres and their management should include regular follow-up and appropriate examinations. To guide treatment strategy, the Task Force suggests performing RHC during follow-up in PAH patients who receive PAH drugs and are at intermediate-low, intermediate-high or high risk of death, when therapeutic consequences are expected. The Task Force does not provide a recommendation for this question in PAH patients at low risk of death, due to the very low certainty of evidence. Conclusion The ERS guidelines on the treatment of PAH provide an updated evidence-based framework for the optimal management of patients with PAH.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
神勇的筝发布了新的文献求助10
刚刚
韭菜馅完成签到 ,获得积分10
1秒前
一只不受管束的小狸Miao完成签到 ,获得积分10
4秒前
动听的诗翠完成签到,获得积分10
4秒前
369ninja发布了新的文献求助10
4秒前
Lsw完成签到 ,获得积分10
5秒前
Laluna的应助被suicone采纳,获得10
6秒前
爱因斯坦坦爷完成签到,获得积分10
7秒前
12秒前
和谐早晨完成签到,获得积分10
15秒前
16秒前
徐土土完成签到 ,获得积分10
17秒前
19秒前
21秒前
大鸣王潮发布了新的文献求助10
22秒前
霹雳蜗牛发布了新的文献求助10
23秒前
latata完成签到 ,获得积分10
23秒前
25秒前
俊逸的幻桃完成签到,获得积分10
27秒前
隔岸完成签到 ,获得积分10
27秒前
28秒前
铭铭完成签到,获得积分10
28秒前
li完成签到 ,获得积分10
28秒前
fangjunya完成签到 ,获得积分10
30秒前
霹雳蜗牛完成签到,获得积分10
31秒前
123发布了新的文献求助10
31秒前
369ninja发布了新的文献求助10
33秒前
Laluna的应助被suicone采纳,获得10
33秒前
大鸣王潮完成签到,获得积分10
34秒前
田様的应助被碧蓝的尔珍采纳,获得10
34秒前
balko完成签到,获得积分10
35秒前
思源的应助被D4C采纳,获得10
36秒前
36秒前
椿·完成签到 ,获得积分10
36秒前
Fred完成签到,获得积分10
41秒前
小雨转晴发布了新的文献求助10
42秒前
42秒前
43秒前
44秒前
44秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179656
求助须知:如何正确求助?哪些是违规求助? 9569921
关于积分的说明 21807706
捐赠科研通 7775141
什么是DOI,文献DOI怎么找? 3433072
关于科研通互助平台的介绍 2557032
邀请新用户注册赠送积分活动 2478778